References
- Shabestari Khiabani S, Farshbaf M, Akbarzadeh A, et al. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol. 2017;45:6–17.
- Farshbaf Davaran M, Rahimi S, Annabi F, et al. Carbon quantum dots: recent progresses on synthesis, surface modification and applications. Artif Cells Nanomed Biotechnol. Forthcoming. [cited 2017 Sep 21]. doi: 10.1080/21691401.2017.1377725.
- Panahi Y, Farshbaf M, Mohammadhosseini M, et al. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications. Artif Cells Nanomed Biotechnol. 2017;45:788–799.
- Panahi Mohammadhosseini Y, Nejati-Koshki MK, Abadi AJN, et al. Preparation, surface properties, and therapeutic applications of gold nanoparticles in biomedicine. Drug Res (Stuttg). 2017;67:77–87.
- Afsharzadeh Hashemi M, Mokhtarzadeh M, Abnous AK, et al. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artif Cells Nanomed Biotechnol. Forthcoming. [cited 2017 Sep 28]. doi: 10.1080/21691401.2017.1376675.
- Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech. 2007;2:751–760.
- Strebhardt K, Ullrich A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8:473–480.
- Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631–651.
- Zhang L, Gu F, Chan J, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:761–769.
- Hiwale P, Lampis S, Conti G, et al. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium. Biomacromolecules. 2011;12:3186–3193.
- Lee W-F, Lee S-C. Effect of gelatin on the drug release behaviors for the organic hybrid gels based on N-isopropylacrylamide and gelatin. J Mater Sci: Mater Med. 2007;18:1089–1096.
- Obata Y, Nishino T, Kushibiki T, et al. HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice. Acta Biomater. 2012;8:2688–2696.
- Chen J-P, Su C-H. Surface modification of electrospun PLLA nanofibers by plasma treatment and cationized gelatin immobilization for cartilage tissue engineering. Acta Biomater. 2011;7:234–243.
- Lee J, Yun K-S, Choi CS, et al. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles. Bioconjugate Chem. 2012;23:1174–1180.
- Shi W, Nie D, Jin G, et al. BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials. 2012;33:3119–3126.
- Wang H, Zhao P, Liang X, et al. Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials. 2010;31:4129–4138.
- Song Y, Zhang L, Gan W, et al. Self-assembled micelles based on hydrophobically modified quaternized cellulose for drug delivery. Colloids Surf B: Biointerfaces. 2011;83:313–320.
- Xu F, Ping Y, Ma J, et al. Comb-shaped copolymers composed of hydroxypropyl cellulose backbones and cationic poly ((2-dimethyl amino) ethyl methacrylate) side chains for gene delivery. Bioconjugate Chem. 2009;20:1449–1458.
- Young SA, HUNG SC, Anderson WH, et al. Effects of cationic hydroxyethyl cellulose on glucose metabolism and obesity in a diet‐induced obesity mouse model. J Diabetes. 2012;4:85–94.
- Cohen JL, Schubert S, Wich PR, et al. Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics. Bioconjugate Chem. 2011;22:1056–1065.
- Kalaska B, Sokolowska E, Kaminski K, et al. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis. Eur J Pharmacol. 2012;686:81–89.
- KaminskiPłonka K, Ciejka M, Szczubiałka J, et al. Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists. J Med Chem. 2011;54:6586–6596.
- Konat Zorzi G, Contreras-Ruiz L, Párraga JE, et al. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles. Mol Pharmaceutics. 2011;8:1783–1788.
- Won Y-W, Yoon S-M, Sonn CH, et al. Nano self-assembly of recombinant human gelatin conjugated with α-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery. ACS Nano. 2011;5:3839–3848.
- Li C, Yuan W, Jiang H, et al. PCL film surfaces conjugated with P (DMAEMA)/gelatin complexes for improving cell immobilization and gene transfection. Bioconjugate Chem. 2011;22:1842–1851.
- MorimotoChono K, Kosai S, Seki TT, et al. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. Drug Deliv. 2008;15:113–117.
- Park C, Vo CL-N, Kang T, et al. New method and characterization of self-assembled gelatin–oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction. Eur J Pharm Biopharm. 2015;89:365–373.
- Choubey J, Bajpai AK. Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J Mater Sci: Mater Med. 2010;21:1573–1586.
- Patra S, Basak P, Tibarewala D. Synthesis of gelatin nano/submicron particles by binary nonsolvent aided coacervation (BNAC) method. Mater Sci Eng C. 2016;59:310–318.
- Gupta AK, Gupta M, Yarwood SJ, et al. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts. J Control Release. 2004;95:197–207.
- Dixit N, Vaibhav K, Pandey RS, et al. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Biomed Pharmacother. 2015;69:1–10.
- Yeh TK, Lu Z, Wientjes MG, et al. Formulating paclitaxel in nanoparticles alters its disposition. Pharm Res. 2005;22:867–874.
- Li W-M, Su C-W, Chen Y-W, et al. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs. Acta Biomater. 2015;15:191–199.
- Cascone MG, Lazzeri L, Carmignani C, et al. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci: Mater Med. 2002;13:523–526.
- Lu Z, Yeh T-K, Tsai M, et al. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004;10:7677–7684.
- Young Lee G, Park K, Nam JH, et al. Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice. J Drug Target. 2006;14:707–716.
- Madan J, Dhiman N, Sardana S, et al. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses. Anti-Cancer Drugs. 2011;22:543–555.
- Dash M, Chiellini F, Ottenbrite R, et al. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981–1014.
- Mukhopadhyay P, Chakraborty S, Bhattacharya S, et al. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol 2015;72:640–648.
- Weecharangsan W, Opanasopit P, Ngawhirunpat T, et al. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm. 2008;348:161–168.
- Thibault M, Astolfi M, Tran-Khanh N, et al. Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials. 2011;32:4639–4646.
- Oh I-h, Min HS, Li L, et al. Cancer cell-specific photoactivity of pheophorbide a–glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials. 2013;34:6454–6463.
- Belalia R, Grelier S, Benaissa M, et al. New bioactive biomaterials based on quaternized chitosan. J Agric Food Chem. 2008;56:1582–1588.
- Dong Y, Ng WK, Shen S, et al. Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers. Carbohydr Polym. 2013;94:940–945.
- Birch NP, Schiffman JD. Characterization of self-assembled polyelectrolyte complex nanoparticles formed from chitosan and pectin. Langmuir. 2014;30:3441–3447.
- Zhou Z, Jiang F, Lee T-C, et al. Two-step preparation of nano-scaled magnetic chitosan particles using Triton X-100 reversed-phase water-in-oil microemulsion system. J Alloys Compounds. 2013;581:843–848.
- Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100:5–28.
- Fan W, Yan W, Xu Z, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B: Biointerfaces. 2012;90:21–27.
- Akbuǧa J, Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int J Pharm. 1994;111:217–222.
- Bodnar M, Hartmann JF, Borbely J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules. 2005;6:2521–2527.
- Raja MA, Shah Z, Arif M, et al. Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery. Int J Nanomed. 2016;11:4397–4412.
- Nag M, Gajbhiye V, Kesharwani P, et al. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Colloids Surf B Biointerfaces. 2016;148:363–370.
- Al-Kassas R, Wen J, Cheng AE, et al. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr Polym. 2016;153:176–186.
- Pramanik A, Laha D, Dash SK, et al. An in-vivo study for targeted delivery of copper-organic complex to breast cancer using chitosan polymer nanoparticles. Mater Sci Eng C Mater Biol Appl. 2016;68:327–337.
- Gonzalez H, Hwang SJ, Davis M. New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate Chem. 1999;10:1068–1074.
- Duran N, Paula Lemes A, B Seabra A. Review of cellulose nanocrystals patents: preparation, composites and general applications. Recent Pat Nanotechnol. 2012;6:16–28.
- Peng B, Dhar N, Liu H, et al. Chemistry and applications of nanocrystalline cellulose and its derivatives: a nanotechnology perspective. Can J Chem Eng. 2011;89:1191–1206.
- Elazzouzi-Hafraoui S, Nishiyama Y, Putaux J-L, et al. The shape and size distribution of crystalline nanoparticles prepared by acid hydrolysis of native cellulose. Biomacromolecules. 2008;9:57–65.
- Ichikawa S, Iwamoto S, Watanabe J. Formation of biocompatible nanoparticles by self-assembly of enzymatic hydrolysates of chitosan and carboxymethyl cellulose. Biosci Biotechnol Biochem. 2005;69:1637–1642.
- Zare-Akbari Z, Farhadnejad H, Furughi-Nia B, et al. PH-sensitive bionanocomposite hydrogel beads based on caborboxymethyl cellulose/ZnO nanoparticle as drug carrier. Int J Biol Macromol. 2016;93:1317–1327.
- Ooi SY, Ahmad I, Amin MCIM. Cellulose nanocrystals extracted from rice husks as a reinforcing material in gelatin hydrogels for use in controlled drug delivery systems. Ind Crops Prod. 2016;93:227–234.
- Ndong Ntoutoume GMA, Granet R, Mbakidi JP, et al. Development of curcumin–cyclodextrin/cellulose nanocrystals complexes: new anticancer drug delivery systems. Bioorg Med Chem Lett. 2016;26:941–945.
- Alibolandi M, Mohammadi M, Taghdisi SM, et al. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017;155:218–229.
- Zhang Z, Chen X, Chen L, et al. Intracellular pH-sensitive PEG-block-acetalated-dextrans as efficient drug delivery platforms. ACS Appl Mater Interfaces. 2013;5:10760–10766.
- Goodwin AP, Tabakman S, Welsher MK, et al. Phospholipid − dextran with a single coupling point: a useful amphiphile for functionalization of nanomaterials. J Am Chem Soc. 2008;131:289–296.
- Lei H, Xie M, Zhao Y, et al. Chitosan/sodium alginate modificated graphene oxide-based nanocomposite as a carrier for drug delivery. Ceram Int. 2016;42:17798–17805.
- Tran NBNN, Knorr F, Mak WC, et al. Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin. Eur J Pharm Biopharm. 2017;116:12–16.
- Abioye AO, Chi GT, Simone E, et al. Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS). Int J Pharm. 2016;509:264–278.
- He S, Zhou D, Kuang H, et al. Dextran-platinum(IV) conjugate as drug carrier for triggered drug release. J Control Release. 2015;213:e96.
- Salimi-Kenari H, Imani M, Nodehi A, Abedini H. An engineering approach to design of dextran microgels size fabricated by water/oil emulsification. J Microencapsul. 2016;33:511–523.
- Suh JW, Lee JS, Ko S, et al. Preparation and characterization of mucoadhesive buccal nanoparticles using chitosan and dextran sulfate. J Agric Food Chem. 2016;64:5384–5388.
- Wu L, Zhang L, Shi G, et al. Zwitterionic pH/redox nanoparticles based on dextran as drug carriers for enhancing tumor intercellular uptake of doxorubicin. Mater Sci Eng C. 2016;61:278–285.
- Li M, Tang Z, Zhang Y, et al. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta Biomater. 2015;18:132–143.
- Saboktakin MR, Tabatabaie RM, Maharramov A, et al. Synthesis and characterization of pH-dependent glycol chitosan and dextran sulfate nanoparticles for effective brain cancer treatment. Int J Biol Macromol. 2011;49:747–751.
- Du Y-Z, Weng Q, Yuan H, et al. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano. 2010;4:6894–6902.
- Wang S, Xu T, Yang Y, et al. Colloidal stability of silk fibroin nanoparticles coated with cationic polymer for effective drug delivery. ACS Appl Mater Interfaces. 2015;7:21254–21262.
- Thomas TJ, Tajmir-Riahi HA, Thomas T. Polyamine–DNA interactions and development of gene delivery vehicles. Amino Acids. 2016;48:2423–2431.
- Walmsley GG, McArdle A, Tevlin R, et al. Nanotechnology in bone tissue engineering. Nanomed Nanotechnol Biol Med. 2015;11:1253–1263.
- Liu Y, Cao X, Luo M, et al. Self-assembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release. J Colloid Interface Sci. 2009;329:244–252.
- Han S, Cheng Q, Wu Y, et al. Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery. Biomaterials. 2015;48:45–55.
- Skarmoutsou A, Lolas G, Charitidis CA, et al. Nanomechanical properties of hybrid coatings for bone tissue engineering. J Mech Behav Biomed Mater. 2013;25:48–62.
- Liu T, Xue W, Ke B, et al. Star-shaped cyclodextrin-poly (l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy. Biomaterials. 2014;35:3865–3872.
- Lam J, Clark EC, Fong EL, et al. Data describing the swelling behavior and cytocompatibility of biodegradable polyelectrolyte hydrogels incorporating poly (L-lysine) for applications in cartilage tissue engineering. Data Brief. 2016;7:614–619.
- Patra D, Sleem F. A new method for pH triggered curcumin release by applying poly (l-lysine) mediated nanoparticle-congregation. Anal Chim Acta. 2013;795:60–68.
- Chen L, Ji F, Bao Y, et al. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Mater Sci Eng C. 2017;70:418–429.
- Chen M, Tang Y, Wang T, et al. Enhanced gene delivery of low molecular weight PEI by flower-like ZnO microparticles. Mater Sci Eng C. 2016;69:1367–1372.
- Dong S, Han L, Cai M, et al. Synthesis of electroactive tetraaniline grafted polyethylenimine for tissue engineering, in. IOP Conf Ser: Mater Sci Eng. 2015;87:012072.
- Jeong H, Lee ES, Jung G, et al. Bioreducible-cationic poly(amido amine)s for enhanced gene delivery and osteogenic differentiation of tonsil-derived mesenchymal stem cells. J Biomed Nanotechnol. 2016;12:1023–1034.
- Rossi E, Gerges I, Tocchio A, et al. Biologically and mechanically driven design of an RGD-mimetic macroporous foam for adipose tissue engineering applications. Biomaterials. 2016;104:65–77.
- Cheng L, Hu Q, Cheng L, et al. Construction and evaluation of PAMAM-DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release properties. Colloids Surf B Biointerfaces. 2015;136:37–45.
- Ko NR, Cheong J, Noronha A, et al. Reductively-sheddable cationic nanocarriers for dual chemotherapy and gene therapy with enhanced release. Colloids Surf B: Biointerfaces. 2015;126:178–187.
- Dragan ES, Loghin DFA, Cocarta A-I, et al. Multi-stimuli-responsive semi-IPN cryogels with native and anionic potato starch entrapped in poly (N, N-dimethylaminoethyl methacrylate) matrix and their potential in drug delivery. React Funct Polym. 2016;105:66–77.
- Du R, Feng X, Chakma A. Poly(N,N-dimethylaminoethyl methacrylate)/polysulfone composite membranes for gas separations. J Membrane Sci. 2006;279:76–85.
- Wang M, Oh JK, Dykstra TE, et al. Surface modification of CdSe and CdSe/ZnS semiconductor nanocrystals with poly (N, N-dimethylaminoethyl methacrylate). Macromolecules. 2006;39:3664–3672.
- Zhang Y, Zheng M, Kissel T, et al. Design and biophysical characterization of bioresponsive degradable poly(dimethylaminoethyl methacrylate) based polymers for in vitro DNA transfection. Biomacromolecules. 2012;13:313–322.
- Salehi R, Hamishehkar H, Eskandani M, et al. Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs. J Drug Target. 2014;22:327–342.
- Tzankova V, Gorinova C, Kondeva-Burdina M, et al. In vitro and in vivo toxicity evaluation of cationic PDMAEMA-PCL-PDMAEMA micelles as a carrier of curcumin. Food Chem Toxicol. 2016;97:1–10.
- Wang X, Jiang G, Wei Z, et al. Preparation and drug release property of CO2 stimulus-sensitive poly(N, N-dimethylaminoethyl methacrylate)-b-polystyrene nanoparticles. Eur Polym J. 2013;49:3165–3170.
- Xiong Q, Zhang M, Zhang Z, et al. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: In vitro and in vivo evaluation. Int J Pharm. 2014;474:232–240.
- Zauner W, Ogris M, Wagner E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Deliv Rev. 1998;30:97–113.
- Sela M, Arnon R, Jacobson I. Synthesis of poly‐L‐lysine and poly‐L‐lysyl albumin via ϵ, N‐trifluoroacetyl‐α, N‐carboxy‐L‐lysine anhydride. Biopolymers. 1963;1:517–525.
- Ahn C-H, Chae SY, Bae YH, et al. Synthesis of biodegradable multi-block copolymers of poly(l-lysine) and poly(ethylene glycol) as a non-viral gene carrier. J Control Release. 2004;97:567–574.
- De S, Robinson D. Polymer relationships during preparation of chitosan–alginate and poly-l-lysine–alginate nanospheres. J Control Release. 2003;89:101–112.
- Liu Y, Liu C, Li M, et al. Polymer–polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly (lactic acid)–poly (ethylene glycol)–poly (L-lysine) to enhance paclitaxel target delivery. J Biomed Nanotechnol. 2014;10:948–958.
- Sasaki H, Karasawa K, Hironaka K, et al. Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes. Eur J Pharm Biopharm. 2013;83:364–369.
- Shi K, Liu Y, Ke L, et al. Epsilon-poly-l-lysine guided improving pulmonary delivery of supramolecular self-assembled insulin nanospheres. Int J Biol Macromol. 2015;72:1441–1450.
- Louis M, Dutoit S, Denoux Y, et al. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther. 2006;13:367–374.
- Jones GD, Langsjoen A, Neumann SMMC, et al. The polymerization of ethylenimine. J Org Chem. 1944;09:125–147.
- von Harpe A, Petersen H, Li Y, et al. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Release. 2000;69:309–322.
- Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem. 2003;14:934–940.
- Liu C, Liu F, Feng L, et al. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials. 2013;34:2547–2564.
- Kim TH, Kim SI, Akaike T, et al. Synergistic effect of poly (ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release. 2005;105:354–366.
- Li Z-T, Guo J, Zhang J-S, et al. Chitosan-graft-polyethylenimine with improved properties as a potential gene vector. Carbohydr Polym. 2010;80:254–259.
- Yu K, Zhao J, Zhang Z, et al. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells. Int J Pharm. 2016;497:78–87.
- Shi J, Zhang H, Wang L, et al. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials. 2013;34:251–261.
- Yu K, Zhao J, Yu C, et al. Role of four different kinds of polyethylenimines (PEIs) in preparation of polymeric lipid nanoparticles and their anticancer activity study. J Cancer. 2016;7:872–882.
- Lin Y-L, Chen C-H, Wu H-Y, et al. Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex. J Nanobiotechnol. 2016;14:11.
- Lin C, Blaauboer C-J, Timoneda MM, et al. Bioreducible poly(amido amine)s with oligoamine side chains: Synthesis, characterization, and structural effects on gene delivery. J Control Release. 2008;126:166–174.
- Sun Y, Deng Z, Tian Y, et al. Horseradish peroxidase‐mediated in situ forming hydrogels from degradable tyramine‐based poly (amido amine) s. J Appl Polym Sci. 2013;127:40–48.
- Zintchenko A, van der Aa LJ, Engbersen JF. Improved synthesis strategy of poly (amidoamine) s for biomedical applications: catalysis by green biocompatible earth alkaline metal salts. Macromol Rapid Commun. 2011;32:321–325.
- Jain R, Standley SM, Frechet JM. Synthesis and degradation of pH-sensitive linear poly (amidoamine) s. Macromolecules. 2007;40:452–457.
- Hu W, Cheng L, Cheng L, et al. Redox and pH-responsive poly (amidoamine) dendrimer–poly (ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release. Coll Surf B: Biointerfaces. 2014;123:254–263.
- Singh M, Pooja K, Kulhari DH, et al. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. Eur J Pharm Sci. 2016;96:84–92.
- Qi X, Qin J, Fan Y, et al. Carboxymethyl chitosan-modified polyamidoamine dendrimer enables progressive drug targeting of tumors via pH-sensitive charge inversion. J Biomed Nanotechnol. 2016;12:667–678.
- Yavuz B, Bozdağ Pehlivan S, Sümer Bolu B, et al. Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation. J Pharm Pharmacol. 2016;68:1010–1020.
- Matai I, Sachdev A, Gopinath P. Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells. Biomater Sci. 2015;3:457–468.